Market Compass
November 2018

Edited by the Macro & Market Research Team.
The team of 13 analysts based in Paris, Cologne, Trieste, Milan and Prague runs qualitative and quantitative analysis on macroeconomic and financial issues.

The team translates macro and quant views into investment ideas that feed into the investment process.

  • After the sharp market correction in October, the Fed, trade war and Italy/European Union (EU) standoff will keep volatility high. But many bad news have been priced in already.

  • However, growth remains solid and the economy is not heading to a recession.

  • Clearer evidence of inflation and labor market tightening will have the Fed continue in its rate hiking. The European Central Bank (ECB) has not signalled any change in policy: Quantitative Easing (QE) will end in December as expected.

  • We remain positioned for a further moderate rise in yields (more so, in Southern Europe), still prefer cash and favor a small overexposure in value equities.

MARKET COMPASS NOVEMBER 2018

RELATED INSIGHTS

COVID-19 FACTS & FIGURES
Sanofi and GSK are in advanced discussion with the European Commission to supply up to 300 million doses of an experimental Covid-19 vaccine.
GLOBAL VIEW – ENJOY SUMMER WHILE IT LASTS
As lockdowns have been lifted and global activity rebounded from the Q2 nadir, hopes of a strong recovery have helped risk assets advance further over July.
Generali Investments among preferred asset managers brands in Europe
We are pleased to share with you the outcome of the first survey on “Preferred Asset Management Firms by European fund selectors” run by Cerulli Associates, in which Generali Investments ranked #11.